Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2012
10/17/2012CN102741240A Pyrimidine compounds as delta opioid receptor modulators
10/17/2012CN102731484A Preparation method for prodigiosins analogue
10/17/2012CN102731417A Dendrimer with alkynyl core and outer amino acid shell, and Huisgen 1,3-dipolar cycloaddition synthetic method and application thereof
10/17/2012CN102731416A 1-(aryl methyl)-quinazoline-2,4-dione as PARP inhibitor and its application
10/17/2012CN102731409A Pyridazinone compound, and pharmaceutical compositions, preparation method and use thereof
10/17/2012CN102731406A Phenanthroimidazole derivatives and application of phenanthroimidazole derivatives in preparation of electroluminescent device
10/17/2012CN102731401A Geldanamycin derivatives, preparation method thereof, and uses thereof
10/17/2012CN101641340B Compound for organic electroluminescent device and organic electroluminescent device
10/17/2012CN101370772B Diketooxime ester compound and use thereof
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288541 Piperazine amide derivatives
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288538 Pyridine derivatives and pyrimidine derivatives (3)
10/16/2012US8288534 Process for the preparation a ruthenium complex
10/16/2012US8288530 Method of preparing macromolecular contrast agents and uses thereof
10/16/2012US8288428 Compounds as cannabinoid receptor ligands
10/16/2012US8288425 Benzimidazoles
10/16/2012US8288403 Heterocyclic gamma secretase modulators
10/16/2012US8288387 Napthalimide-benzimidazole hybrids as potential antitumor agents and process for the preparation thereof
10/16/2012US8288386 Melanocortin receptor agonists
10/16/2012US8288385 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
10/16/2012US8288373 Modulators of CXCR7
10/16/2012US8288371 Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
10/16/2012US8288318 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
10/16/2012US8288316 N-(1,2,5-oxadiazol-3-yl)benzamides and their use as herbicides
10/16/2012US8287769 Charge transport compositions and electronic devices made with such compositions
10/16/2012CA2605680C Substituted amide derivatives as protein kinase inhibitors
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2526866C Substituted 3-sulfur indoles for treating a disease mediated by crth2
10/11/2012WO2012138877A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
10/11/2012WO2012138715A2 Small molecule inhibitors of xbp1 splicing
10/11/2012WO2012138147A2 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
10/11/2012WO2012137958A1 Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device
10/11/2012WO2012137099A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
10/11/2012WO2012136834A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012WO2012136492A1 Wnt pathway antagonists
10/11/2012WO2012103295A3 Small molecule rnase inhibitors and methods of use
10/11/2012WO2012096929A3 Heteroaryl compounds and methods of use thereof
10/11/2012WO2012083306A3 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
10/11/2012WO2012083058A3 Anti-viral compounds
10/11/2012US20120259113 Dual-acting pyrazole antihypertensive agents
10/11/2012US20120258963 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/11/2012US20120258951 Novel antiplatelet agent
10/11/2012US20120258946 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands
10/11/2012US20120258078 Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis c
10/11/2012US20120256174 Compound for an organic photoelectric device, organic photoelectric device including the same, and display device including the organic photoelectric device
10/11/2012US20120256173 Charge transporting material and organic electroluminescence device
10/11/2012CA2832685A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012CA2832305A1 Wnt pathway antagonists
10/11/2012CA2830958A1 N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods
10/11/2012CA2830866A1 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
10/10/2012EP2507232A2 Proline derivatives
10/10/2012EP2507211A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10/10/2012CN102725284A Compound suitable for the treatment of synucleopathies
10/10/2012CN102725283A Compounds and compositions as protein kinase inhibitors
10/10/2012CN102725268A Compounds for electronic devices
10/10/2012CN102724981A Method for predicting therapeutic effect of chemotherapy on hepatocellular carcinoma patient
10/10/2012CN102718748A Compounds having analgesic and/or immunostimulant activity
10/10/2012CN102718715A Imidazole salt type nonlinear optical material and preparation method and application thereof
10/10/2012CN102718708A Novel nitrogen-containing heteroaryl compounds and methods of use thereof
10/10/2012CN101541764B Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
10/10/2012CN101479249B Benzimidazole derivatives, method for the production thereof, their use as FXR agonists and pharmaceutical preparations containing the same
10/10/2012CN101450934B Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/10/2012CN101370784B Compound serving as ERK inhibitors
10/10/2012CN101360739B Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes
10/10/2012CN101274932B 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof
10/10/2012CN101263112B Histamine H3 receptor agents, preparation and therapeutic uses
10/10/2012CN101142194B Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
10/10/2012CN101023074B Inhibitors of the interaction between MDM2 and P53
10/10/2012CN101018772B Neurologically-active compounds
10/09/2012US8283474 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
10/09/2012US8283356 2,4- Di(hetero)-arylamino-pyrimidine derivatives as ZAP-70 and/or SYK inhibitors
10/09/2012US8283053 Fluoranthene derivative and organic light emitting device having the same
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2551788C Novel carboxamides for use as xa inhibitors
10/09/2012CA2526455C 5-membered heterocycle-based p38 kinase inhibitors
10/09/2012CA2507100C 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/04/2012WO2012135697A2 Novel rho kinase inhibitors and methods of use
10/04/2012WO2012135641A2 Aurora kinase inhibitors and methods of making and using thereof
10/04/2012WO2012135441A1 Penoxsulam as an herbicide in alfalfa
10/04/2012WO2012135175A1 (alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012WO2012135166A1 (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012WO2012135160A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases
10/04/2012WO2012135112A2 Methods for preparing deuterated 1,2,3-triazoles
10/04/2012WO2012134351A1 Clathrate complexes of beta-cyclodextrin and 5-hydroxy-4-aminomethyl-1-cyclohexyl (or cycloheptyl)-3-alkoxycarbonyl indole derivative, which exhibit an anti-viral effect, and methods for producing said complexes
10/04/2012WO2012134124A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
10/04/2012WO2012133607A1 Pyrazole compound
10/04/2012WO2012133509A1 Novel benzimidazole derivative
10/04/2012WO2012131501A1 Substituted benzimidazole compounds as cot kinase inhibitors
10/04/2012WO2012131389A1 Process for the preparation of 1 - ( 2 -methyl - 4 - ( 2, 3, 4, 5 - tetrahydro - 1 - benzazepin- 1 -ylcarbonyl) benzylcarbamoyl) - l - proline - n, n- dimethylamide
10/04/2012WO2012131031A1 New positive allosteric modulators of nicotinic acetylcholine receptor
10/04/2012WO2012130905A1 Substituted benzimidazoles
10/04/2012WO2012130679A1 New azaspirodecanone compounds as hsl inhibitors
10/04/2012WO2012130633A1 Pyrazole compounds as crth2 antagonists
10/04/2012WO2012129792A1 Pyrimidinone compounds, preparation methods, pharmaceutical compositions and uses thereof
10/04/2012WO2010076805A3 Novel polymorphs of sunitinib malate
10/04/2012US20120253052 Methods and intermediates for the synthesis of porphyrins
10/04/2012US20120253039 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
10/04/2012US20120253038 Processes for the synthesis of bazedoxifene acetate and intermediates thereof
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 626